- Home
- AAP vs SRRK Comparison
AAP vs SRRK Comparison
Compare AAP & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAP
- SRRK
- Stock Information
- Founded
- AAP 1929
- SRRK 2012
- Country
- AAP United States
- SRRK United States
- Employees
- AAP N/A
- SRRK N/A
- Industry
- AAP Auto & Home Supply Stores
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AAP Consumer Discretionary
- SRRK Health Care
- Exchange
- AAP Nasdaq
- SRRK Nasdaq
- Market Cap
- AAP 3.3B
- SRRK 3.0B
- IPO Year
- AAP N/A
- SRRK 2018
- Fundamental
- Price
- AAP $50.70
- SRRK $29.37
- Analyst Decision
- AAP Hold
- SRRK Strong Buy
- Analyst Count
- AAP 19
- SRRK 9
- Target Price
- AAP $52.45
- SRRK $47.88
- AVG Volume (30 Days)
- AAP 1.9M
- SRRK 3.2M
- Earning Date
- AAP 10-30-2025
- SRRK 11-14-2025
- Dividend Yield
- AAP 1.97%
- SRRK N/A
- EPS Growth
- AAP N/A
- SRRK N/A
- EPS
- AAP N/A
- SRRK N/A
- Revenue
- AAP $8,624,327,000.00
- SRRK N/A
- Revenue This Year
- AAP N/A
- SRRK N/A
- Revenue Next Year
- AAP $1.00
- SRRK $1,911.27
- P/E Ratio
- AAP N/A
- SRRK N/A
- Revenue Growth
- AAP N/A
- SRRK N/A
- 52 Week Low
- AAP $28.89
- SRRK $22.71
- 52 Week High
- AAP $70.00
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- AAP 37.32
- SRRK 40.83
- Support Level
- AAP $52.81
- SRRK $28.82
- Resistance Level
- AAP $57.73
- SRRK $31.85
- Average True Range (ATR)
- AAP 3.02
- SRRK 1.92
- MACD
- AAP 0.02
- SRRK -0.25
- Stochastic Oscillator
- AAP 10.65
- SRRK 22.54
About AAP Advance Auto Parts Inc.
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.